Woodline Partners LP Bolt Biotherapeutics, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $1.11 Million - $1.94 Million	-403,357 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.19 - $13.97 $37,743 - $125,841	9,008 Added 2.28%	403,357 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$11.15 - $18.6 $141,337 - $235,773	12,676 Added 3.32%	394,349 $4.99 Million
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $116,285 - $237,554	7,551 Added 2.02%	381,673 $5.9 Million
Q1 2021 May 17, 2021	BUY	$25.86 - $39.93 $9.67 Million - $14.9 Million	374,122 New	374,122 $12.3 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.